These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12076404)

  • 1. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
    Youssef MA; Al-Inany HG; Evers JL; Aboulghar M
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001302. PubMed ID: 21328249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review.
    Aboulghar M; Evers JH; Al-Inany H
    Hum Reprod; 2002 Dec; 17(12):3027-32. PubMed ID: 12456597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
    Youssef MA; Mourad S
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryo freezing for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002806. PubMed ID: 17636707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 1996 Apr; (1):CD000087. PubMed ID: 17636586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad S; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabergoline for preventing ovarian hyperstimulation syndrome.
    Tang H; Hunter T; Hu Y; Zhai SD; Sheng X; Hart RJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008605. PubMed ID: 22336848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (3):CD002811. PubMed ID: 12137659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
    Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; (2):CD000097. PubMed ID: 10796488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van Der Veen F
    Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van der Veen F
    Cochrane Database Syst Rev; 2004; 2003(1):CD000412. PubMed ID: 14973957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
    Al-Inany HG; Youssef MA; Aboulghar M; Broekmans F; Sterrenburg M; Smit J; Abou-Setta AM
    Cochrane Database Syst Rev; 2011 May; (5):CD001750. PubMed ID: 21563131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Brown J; Amso NN
    Cochrane Database Syst Rev; 2011 Jun; (6):CD002811. PubMed ID: 21678336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.